Search

Author/Creator Seki, Yoshifumi

1. Efficacy and safety of once‐weekly oral trelagliptin switched from once‐daily dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: An open‐label, phase 3 exploratory study. Issue 2 (30th October 2017)

Authors:
Inagaki, Nobuya; Sano, Hiroki; Seki, Yoshifumi; Kuroda, Shingo; Kaku, Kohei
Journal:
Journal of diabetes investigation
Issue:
Volume 9:Issue 2(2018)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long‐term safety and efficacy of a novel once‐weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52‐week open‐label, phase 3 study. Issue 5 (28th March 2016)

Authors:
Inagaki, Nobuya; Sano, Hiroki; Seki, Yoshifumi; Kuroda, Shingo; Kaku, Kohei
Journal:
Journal of diabetes investigation
Issue:
Volume 7:Issue 5(2016:Oct.)
Page Start:
718
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗